Mylan/King Merger, GSK's Fluarix Expected To Highlight Oct. 28 Earnings Calls
This article was originally published in The Pink Sheet Daily
Executive Summary
Also reporting on Oct. 28 are Elan, ImClone and Medco. Final heavy week of quarterly pharma earnings updates include Oct. 27 reports by P&G, Merck KGaA and Novo Nordisk.